Literature DB >> 6639227

Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.

A S Cross, S Opal, D J Kopecko.   

Abstract

During a five-year period at Walter Reed Army Hospital, Washington, DC, the frequency of aminoglycoside resistance among clinical bacterial isolates increased from less than 1% in 1976 to 13% of all isolates in later years. This resistance was seen among frequently isolated species of gram-negative bacilli isolated from patients throughout the hospital and from all anatomical sites, including blood. The incidence of gentamicin and amikacin resistance rose with increased administration of these antibiotics; however, the incidence of tobramycin resistance increased despite its minimal usage. From 1977 to 1978 and from 1979 to 1980, there was a decrease in the conjugal transmissibility of resistance to gentamicin and tobramycin. There was no detectable transmissible amikacin resistance. These findings suggest that high priority must be given to strategies that limit the emergence and dissemination of organisms resistant to these important antibiotics.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639227

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Fluoroquinolones in urinary tract infections. Proper and improper use.

Authors:  K G Naber
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.

Authors:  R Vanhoof; J M Hubrechts; H J Nyssen; E Roebben
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 3.  Is antimicrobial resistance in hospital microorganisms related to antibiotic use?

Authors:  J E McGowan
Journal:  Bull N Y Acad Med       Date:  1987-04

4.  Novel Aminoglycoside-Tolerant Phoenix Colony Variants of Pseudomonas aeruginosa.

Authors:  Devin Sindeldecker; Kelly Moore; Anthony Li; Daniel J Wozniak; Matthew Anderson; Devendra H Dusane; Paul Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

5.  Paediatric nosocomial urinary tract infection at a regional hospital.

Authors:  F A Orrett; P J Brooks; E G Richardson; S Mohammed
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

6.  Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.

Authors:  A Brauner; S J Cryz; M Granström; H S Hanson; L Löfstrand; B Strandvik; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

7.  Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital.

Authors:  D N Gerding; T A Larson; R A Hughes; M Weiler; C Shanholtzer; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

9.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Authors:  G A Jacoby; M J Blaser; P Santanam; H Hächler; F H Kayser; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 10.  Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.